Ulrike Gnad-Vogt

1.8k citations
28 papers · 1.0k indexed · 1 hit paper · h-index 11
Topics
Immunotherapy and Immune Responses (15 papers)Cancer Immunotherapy and Biomarkers (10 papers)RNA Interference and Gene Delivery (7 papers)
Partner nations
GermanySwitzerlandFrance

In The Last Decade

Ulrike Gnad-Vogt

27 papers receiving 992 citations

Hit Papers

Safety and immunogenicity of a mRNA rabies vaccine in hea...20172026202020232017100200300

Peers

Ulrike Gnad-Vogt
Comparison fields: 5 of 62
  • Molecular Biology 649
  • Immunology 496
  • Infectious Diseases 279
  • Oncology 257
  • Genetics 144
Replace Nitya Nair with:
Nitya Nair United States
Jochen Probst Germany
Steven Tuyishime United States
Gustaf Lindgren Sweden
Kimberly Denis-Mize United States
Marie J. Estcourt Australia
Michelle C. Crank United States
Henoch S. Hong Germany
Lars Frelin Sweden
Michela Brazzoli Italy
Ulrike Gnad-Vogt relative to Nitya Nair United States Nitya Nair's profile →
Citations per field
00.5×1.5×1.9×
Nitya Nair · 1×
Citations per year

Countries citing papers authored by Ulrike Gnad-Vogt

Since Specialization
Citations

This map shows the geographic impact of Ulrike Gnad-Vogt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Gnad-Vogt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Gnad-Vogt more than expected).

Fields of papers citing papers by Ulrike Gnad-Vogt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Gnad-Vogt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Gnad-Vogt. The network helps show where Ulrike Gnad-Vogt may publish in the future.

Co-authorship network of co-authors of Ulrike Gnad-Vogt

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Gnad-Vogt. A scholar is included among the top collaborators of Ulrike Gnad-Vogt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Gnad-Vogt. Ulrike Gnad-Vogt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 3
5 37
6 32
7
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trialbreakdown →
373
8 1
9 18
10 18
11 211
12 113
13 93
14 5
15 26
16 6
17 45
18 1
19 1
20 9

About Ulrike Gnad-Vogt

Ulrike Gnad-Vogt is a scholar working on Immunology, Oncology and Virology, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Immunology (496 citations), Infectious Diseases (279 citations) and Virology (48 citations). Ulrike Gnad-Vogt has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include Mariola Fotin‐Mleczek, Sven D. Koch, Ingmar Hoerr, Henoch S. Hong, Linus Backert, Greg Finak, Raphaël Gottardo, Ralf Clemens, Martin Alberer and Keyvan Tadjalli Mehr. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026